1.37
Mindwalk Holdings Corp stock is traded at $1.37, with a volume of 462.76K.
It is down -8.05% in the last 24 hours and down -47.51% over the past month.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
See More
Previous Close:
$1.49
Open:
$1.49
24h Volume:
462.76K
Relative Volume:
1.01
Market Cap:
$63.97M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-2.84%
1M Performance:
-47.51%
6M Performance:
+0.00%
1Y Performance:
+0.00%
Mindwalk Holdings Corp Stock (HYFT) Company Profile
Compare HYFT vs VRTX, REGN, ARGX, ALNY, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HYFT
Mindwalk Holdings Corp
|
1.37 | 69.57M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Mindwalk Holdings Corp Stock (HYFT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-22 | Initiated | H.C. Wainwright | Buy |
| Oct-25-21 | Initiated | The Benchmark Company | Buy |
Mindwalk Holdings Corp Stock (HYFT) Latest News
MindWalk Uses HYFT AI Platform to Expose Hidden Portfolio and IP Risks in Drug Discovery - TipRanks
MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Yahoo Finance
MindWalk Launches HYFT Technology to Address Drug Development Risks - intellectia.ai
After Leaping 47% MindWalk Holdings Corp. (NASDAQ:HYFT) Shares Are Not Flying Under The Radar - 富途牛牛
MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - BioSpace
Mindwalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic Tdp-43 in Neurodegenerative Disease - marketscreener.com
Scientists trace a hidden flu constraint across strains and hosts - Stock Titan
REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Yahoo Finance
MindWalk (HYFT) Makes Progress in Influenza Research with Key Di - GuruFocus
MindWalk Holdings Corp. Advances Universal Influenza Program with A Breakthrough Functional Insight - marketscreener.com
MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - 01net
MindWalk Unveils Cross-Strain Functional Constraint to Advance Universal Flu Vaccine Effort - TipRanks
MindWalk : Charter of the Audit Committee of the Board of Directors - marketscreener.com
MindWalk Holdings Corp.'s (NASDAQ:HYFT) P/S Is Still On The Mark Following 38% Share Price Bounce - Sahm
MindWalk Holdings Corp. (HYFT) Competitors - Meyka
12 Health Care Stocks Moving In Monday's After-Market Session - Sahm
HYFT: MindWalk Holdings Corp.Balance Sheet - Zacks Investment Research
MindWalk Holdings Corp. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:HYFT) 2025-12-18 - Seeking Alpha
MindWalk Holdings Corp. (HYFT) reports Q2 loss, lags revenue estimates - MSN
MindWalk : Second Quarter 2026 Transcript - marketscreener.com
MindWalk reports 54% revenue growth in Q2 fiscal 2026 By Investing.com - Investing.com Australia
MindWalk Holdings Corp.Common Stock (NQ: HYFT - Markets Financial Content
MindWalk Holdings Corp. (HYFT) Reports Q2 Loss, Lags Revenue Estimates - sharewise.com
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Innovations - GuruFocus
MindWalk Holdings Corp (HYFT) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
HYFT Stock Price and Chart — NASDAQ:HYFT - TradingView — Track All Markets
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth By Investing.com - Investing.com South Africa
Earnings call transcript: MindWalk’s Q2 2025 sees 54% revenue growth - Investing.com
MindWalk Holdings Corp. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2025 - marketscreener.com
MindWalk Reports Record Growth and Announces Strategic Progress on Its AI Asset Pipeline - Business Wire
MindWalk reports 54% revenue growth in Q2 fiscal 2026 - Investing.com India
MindWalk Holdings (HYFT) Reports Strong Revenue Growth Despite E - GuruFocus
MindWalk Holdings Emphasizes AI-Driven Strategy in Latest Financial Release - TipRanks
MindWalk Holdings Corp. (HYFT) provides Q2 MD&A and financials update - Stock Titan
[6-K] MindWalk Holdings Corp. Current Report (Foreign Issuer) | HYFT SEC FilingForm 6-K - Stock Titan
Stock Market Today: Dow Futures, S&P 500 Advance Ahead Of Key Economic Data: iRobot, Argenx, MindWalk In Focus - Benzinga
Why MindWalk Holdings Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket - Sahm
Argenx, Navan And 3 Stocks To Watch Heading Into Monday - Benzinga
Here are the major earnings before the open Monday - MSN
mindwalk holdings corp. Earnings dates - RTTNews
Pre-Market Earnings Report for December 15, 2025 : HYFT - Nasdaq
Earnings Outlook For ImmunoPrecise Antibodies - Benzinga
Mindwalk Holdings Corp Stock (HYFT) Financials Data
There is no financial data for Mindwalk Holdings Corp (HYFT). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):